Key result
Cardiac surgery-associated acute kidney injury is a common complication with limited evidence-based treatments beyond supportive care, leading to significant and growing economic costs.
This review highlights the growing economic and clinical burden of CSA-AKI, emphasizing the need for early biomarker-based identification and validated preventive interventions.
No takes yet. Share an insight, caveat, or question.
Should not yet change CSA-AKI diagnostic or preventive practice; leaves open prospective trials of injury-biomarker–guided care bundles.
Schurle et al. (2021) conducted a review in Cardiac surgery-associated acute kidney injury (CSA-AKI). Cardiac surgery-associated acute kidney injury is a common complication with limited evidence-based treatments beyond supportive care, leading to significant and growing economic costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: